This year the United European Gastroenterology Week took place from October 24th to 28th in Barcelona. Over 13 000 participants from 114 countries were present. The BÜHLMANN team was among the 2325 exhibitors. This year’s UEGW marked an important event for us with the publication of the first clinical usability evaluation of IBDoc®. The data was
- info@buhlmannlabs.ch
- +41 61 487 12 12
Tag Archives: ibdoc
Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis.
BÜHLMANN launched www.ibdoc.net at this year’s UEGW in Vienna. This new website serves as a platform to inform a broad audience about the BÜHLMANN Calprotectin Home Test called IBDoc®. It will also be the first point of contact for IBDoc® users to receive support in the form of Frequently Asked Questions, Instruction for Use documents
The BÜHLMANN Press Release on the Calprotectin home test for the Fight IBD day at ECCO 2014 Copenhagen. Link to Press Release For further reading on the topic you find links here: – Fecal Calprotectin correlates more closely with the simple endoscopic score for Crohns Disease than CRP, Blood Leukocytes, and the CDAI. Schöpfer et
Social Links